Ok Let's try to clear this up as far as the amount of
Ok Let's try to clear this up as far as the amount of spending towards R&D is concerned and why it appears to be "ridiculously low". FELLER you are absolutely right about the incentives offered to the OWCP doctors and research team as one way of keeping the costs down. Triple9 you are absolutely wrong, and reckless I might add, in making the statement that the "amounts and ratios are a red flag".
For the others here that might have thought the same thing, the amount spent on R&D is low for a reason. They are not a sign of a red flag!!!! Read the 10-Q and the 10-K and for that matter other reports that have been filed. You keep coming across the term "Collaboration Agreements". With regards to R&D the principal Collaborator is Sheba Academic Medical Center. If it were not for relinquishing some of the intellectual property rights to Sheba, the fees paid to them would be much much higher. I think this is a smart way of keeping costs down. Give management credit.
While we retain full ownership on our intellectual property rights that we conceived prior to the signing of the research collaboration and license agreements with Sheba Academic Medical Center, the psoriasis and fibromyalgia agreements with Sheba provide that all intellectual property rights that is conceived during the course of the research is to be jointly owned by Sheba and One World Cannabis.
With all due respect, please read the reports and try to put two and two together before you and others make statements that can be taken the wrong way and serve no purpose other than to give people with different agendas the opportunity to capitalize and buy shares at a cheap price.
4
1
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Art of Choosing the Right Dumpster When you're up against a home cleanout or remodel, the dumpster's a hero you didn't know you needed. For folks in Roseburg, Oregon, this comes down to the savvy words of Dori John, a waste management expert who's got the lowdown on dumpster decision-making. Think you can just guess how big a container you need by eyeballing your...
Continue Reading
AI's Growing Footprint in Global Strategies Let's get straight to it: AI's not just playing in the background anymore—it's front and center, dipping its fingers into everything from budget spreadsheets to boardroom agendas. Infotech's annual Tech Trends 2027 report isn't mincing words about AI either, spotlighting 14 trends across four themes that tech leaders better be...
Continue Reading
Riding the Aging Wave in Columbus The Perfect Companion is no stranger to the ups and downs of the eldercare industry. Celebrating five years in Columbus, this eldercare outfit's trying to pull off what many can't—a solid expansion in a landscape where finding reliable home care employees is about as easy as pulling teeth. But here they are, aiming to hire 25 more...
Continue Reading
A Major Step Forward in AI Infrastructure When two heavyweights clash, you better believe folks are paying attention. OneQode’s deal with AdaniConneX is like a shot across the bow in the AI infrastructure arena. They’re not just dipping a toe in India’s tech waters; they’re diving headfirst with 14 MW of data center muscle right there in Siruseri Sipcot, Chennai....
Continue Reading
China's Capital Markets: A New Era Dawns Guosen Securities is ringing the bell for a fundamental shift in China's capital markets, folks. As we're about to roll into the 15th Five-Year Plan period, they're not just talking about expansion anymore. Nope, it's all about reshaping the landscape with regulatory reforms, innovation, and international integration. If you think...
Continue Reading
Beta Bionics Takes a Hit: What's Behind the Drop? You ever have one of those moments where you wonder if you missed a memo? Well, folks investing in Beta Bionics (NASDAQ:BBNX) sure might feel that way after a staggering 37% plunge in their stock. The issue here isn't just the drop—it's what spurred it: a securities class action lawsuit alleging some murky disclosures...
Continue Reading
Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...
Continue Reading
Shifting Gears: Patriot Growth's New Leadership Turn When it comes to tightening the ship and pointing towards uncharted waters, new leadership can be the key. This couldn't be more true for Patriot Growth Insurance Services as they welcome Rajeev Jain aboard as their latest Chief Operating Officer. This move is all about reinforcing their commitment to operational...
Continue Reading
Bracco's Bold Move into U.S. Manufacturing In the bustling world of diagnostic imaging, Bracco's latest announcement is like a welcome jolt. They're shelling out $230 million for a new manufacturing facility in Sanford, North Carolina. If you've been around the block in this sector, this move screams ambition—Bracco's playing the long game here. Strategic Location: A...
Continue Reading
The Surge in Popularity of Manual Lymphatic Massage There's a whole lotta buzz around manual lymphatic drainage (MLD) these days, and folks want to know if all that hype's got any juice. During National Massage Therapy Awareness Week, the American Massage Therapy Association (AMTA) lent a hand by spotlighting what the latest research has to say about this specialized...
Continue Reading
Top 5 Most Recently Viewed Articles
CompTIA's Upcoming Session at TechNet Augusta Conference CompTIA is set to present a significant session at the upcoming TechNet Augusta conference, focusing on how people, data, and artificial intelligence (AI) can come together to enhance the readiness of cybersecurity. This session is an integral part of the CompTIA Learning Solutions Series, scheduled for a day...
Continue Reading
Laura Mercier Launches on Amazon Premium Beauty Award-winning beauty brand Laura Mercier has officially launched on the Amazon U.S. Premium Beauty Store, enhancing accessibility to high-quality beauty products. Renowned for its artistry-inspired makeup and skincare lines, Laura Mercier is now joining forces with Amazon, making it easier for beauty enthusiasts everywhere...
Continue Reading
Truist Adjusts Merck's Price Target Recently, Truist Securities revised its price target for Merck & Co., Inc. (NYSE:MRK) from $143.00 down to $132.00. Despite this adjustment, they continue to maintain a Buy rating for the stock, showcasing their confidence in its long-term potential. Impact of the Recent Acquisition This downgrade comes on the heels of Merck's...
Continue Reading
Xilio Therapeutics Expands Team with Stock Options Grant Xilio Therapeutics, Inc. (Nasdaq: XLO), a cutting-edge biotechnology firm focused on developing tumor-activated immuno-oncology therapies, is making significant strides in its mission to support those living with cancer. In an exciting development, the company has announced the granting of a non-qualified stock...
Continue Reading
For the analytical investor, every property acquisition begins with the numbers. In Portugal, a market celebrated for its steady growth and robust financial incentives, understanding mortgage dynamics is essential to making sound investment decisions. You might find that a deep dive into Portugal’s mortgage landscape reveals both challenges and substantial...
Continue Reading
